These findings are consistent with previous studies showing that GPER selective agonists disrupt spindle formation and thus arrest cell cycle at prophase of mitosis in ovarian cancer [31], and induce caspase- dependent and independent programmed cell death [61,62]. This evidence concerns the gene GPER1 and ovarian carcinoma.